Opus Genetics Inc. — Form D
Opus Genetics Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-27. The offering totals $20.0M, of which $4.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-06-27
- Form: D
- Accession: 0001877769-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $4.5M
- Remaining: $15.5M
- Investors: 5
- Date of first sale: 2023-06-05
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-485315
Issuer
- Name: Opus Genetics Inc.
- CIK: 0001877769
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 8 DAVIS DRIVE, DURHAM, NC, 27709
- Phone: 919-525-9820
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| JEAN R BENNETT | Director | DURHAM, NC |
| ADRIENNE R GRAVES | Director | DURHAM, NC |
| RUSSELL R KELLEY | Director | DURHAM, NC |
| BENJAMIN R YERXA | Director | DURHAM, NC |
| BENJAMIN R YERXA | Executive Officer | DURHAM, NC |
| RUSSELL R KELLEY | Executive Officer | DURHAM, NC |
Other filings by this issuer (1)
More